## **Core Concept**
TIPSS stands for Transjugular Intrahepatic Portosystemic Shunt. It is a medical intervention used primarily to treat complications of portal hypertension, such as refractory ascites and variceal bleeding. The procedure involves creating a shunt between the hepatic vein and the portal vein to reduce portal pressure.

## **Why the Correct Answer is Right**
The correct answer, , refers to **Hepatic Encephalopathy**. This is a well-recognized early complication of TIPSS. The creation of a shunt between the portal and hepatic veins can allow ammonia and other neurotoxic substances, normally detoxified by the liver, to bypass hepatic metabolism and directly enter the systemic circulation. This can precipitate or worsen hepatic encephalopathy in susceptible patients.

## **Why Each Wrong Option is Incorrect**
- **Option A:** - While infection can be a complication of many medical procedures, it is not as specifically or uniquely associated with TIPSS as hepatic encephalopathy.
- **Option B:** - This option likely refers to another potential complication but is not specified; however, based on the context, it's clear that hepatic encephalopathy is a more direct and common early complication.
- **Option D:** - This option might refer to shunt dysfunction or another complication but is not identified; the focus here is on why hepatic encephalopathy stands out as a correct early complication.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients undergoing TIPSS are at risk of developing **hepatic encephalopathy**, and prophylactic measures such as lactulose and rifaximin may be used to mitigate this risk. TIPSS is often considered for patients with refractory ascites or variceal bleeding who have not responded to endoscopic and pharmacological treatments.

## **Correct Answer:** . Hepatic Encephalopathy